Following the news from Africa

Provided by AGP

Times Reporter of Africa: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Times Reporter of Africa.

Press releases published on April 28, 2026

Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics
Juniper Biosciences Announces Strategic Collaboration with leading global cancer center on F-MISO (JBS-003): A First-in-Class Precision Diagnostic Poised to Revolutionize Head and Neck Cancer Treatment
CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation
Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
BridgeBio Launches Health Education Effort on Often Overlooked Heart Condition Featuring Attruby® Advocates, Morgan Freeman and Sports Business Icon Howard H. White
DEEP SEA MINERALS CORP. HIGHLIGHTS KEY TAKEAWAYS FROM DEEP SEA MINING SUMMIT 2026 IN LONDON
InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement
Avicanna Welcomes Initial U.S. Rescheduling of Medical Cannabis & Provides Scientific Update
BioCryst to Present at Upcoming Investor Conferences
Ocular Therapeutix™ to Report First Quarter 2026 Financial Results on May 5, 2026
Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting
Stallion Uranium Recommences Drilling at Moonlite Project
MEXC Lists Pharos (PROS) in Innovation Zone with 41,667 PROS and 10,000 USDT Airdrop+ Rewards
Reacta Healthcare Announces Expansion into Asia-Pacific and Appoints Professor Gary Wing-Kin Wong to Advisory Board
Precore Gold Welcomes Tenured Geologist Raúl Carbajal as Senior Project Manager at Its Arikepay Project in Peru
Scancell receives FDA Fast Track Designation for iSCIB1+ in advanced melanoma and provides data update from its SCOPE Phase 2 study

Share us

on your social networks:

Sign up for:

Times Reporter of Africa

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.